Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Pancreatic cancer is a lethal malignancy with limited therapeutic options.
• Conventional cytotoxic chemotherapies offer modest survival benefits but cause significant toxicity.
• The dense desmoplastic stroma and tumor microenvironment are critical in pancreatic cancer progression, drug resistance, and immune evasion.

Purpose of the Study:

• To review novel therapeutic strategies targeting the pancreatic tumor microenvironment.
• To discuss preclinical rationales and ongoing clinical evaluations of these emerging therapies.

Main Methods:

• Literature review of preclinical studies and clinical trials.
• Analysis of therapeutic strategies focusing on tumor-stromal interactions.

Main Results:

• Emerging therapies aim to overcome limitations of conventional treatments by targeting the tumor microenvironment.
• Several novel approaches are in or near clinical evaluation, showing potential to improve treatment efficacy.

Conclusions:

• Understanding tumor-stromal interactions is key to developing more effective pancreatic cancer therapies.
• Targeting the tumor microenvironment represents a promising frontier in pancreatic cancer treatment, offering hope for improved patient survival and reduced toxicity.